Wali F A, Greenidge E
Jpn J Physiol. 1986;36(4):807-13. doi: 10.2170/jjphysiol.36.807.
Verapamil (0.05-5 microM), diltiazem (0.2-20 microM), and nifedipine (0.3-30 microM) produced concentration-dependent relaxation of bovine coronary artery. Based on the EC50 values (concentration to produce 50% maximum response), the calcium entry blocker verapamil (relative potency = 1) was 3.4 and 7 times as potent as diltiazem and nifedipine, respectively, in producing relaxation of bovine coronary artery. In addition, verapamil reduced the contractions produced by acetylcholine (0.01-10 microM), 5-hydroxytryptamine (5-HT) (0.01-10 microM) whereas it potentiated the relaxation produced by noradrenaline (0.01-10 microM). It was concluded that verapamil, diltiazem, and nifedipine (a) relax the bovine coronary artery, verapamil being more potent than diltiazem and nifedipine, and (b) the calcium entry blockers modified the contractile responses to neurotransmitter agents, acetylcholine, noradrenaline, and 5-HT, inhibiting the contractions produced by acetylcholine and 5-HT, and enhancing the relaxation produced by noradrenaline.
维拉帕米(0.05 - 5微摩尔)、地尔硫䓬(0.2 - 20微摩尔)和硝苯地平(0.3 - 30微摩尔)可使牛冠状动脉产生浓度依赖性舒张。根据半数有效浓度值(产生最大反应50%时的浓度),钙通道阻滞剂维拉帕米(相对效能 = 1)在使牛冠状动脉舒张方面,其效能分别是地尔硫䓬和硝苯地平的3.4倍和7倍。此外,维拉帕米可减弱乙酰胆碱(0.01 - 10微摩尔)、5 - 羟色胺(5 - HT)(0.01 - 10微摩尔)所引起的收缩,而增强去甲肾上腺素(0.01 - 10微摩尔)所引起的舒张。研究得出结论:维拉帕米、地尔硫䓬和硝苯地平(a)可使牛冠状动脉舒张,维拉帕米的效能高于地尔硫䓬和硝苯地平;(b)钙通道阻滞剂可改变对神经递质乙酰胆碱、去甲肾上腺素和5 - HT的收缩反应,抑制乙酰胆碱和5 - HT所引起的收缩,并增强去甲肾上腺素所引起的舒张。